SlideShare a Scribd company logo
1 of 34
DEPARTMENT of CHILDREN's
infectious diseases
Discipline: Children's infectious
diseases
Topic of the lecture: Infectious mononucleosis in children
4 course, level of development: DT, P
Lecturer: assistant Erzhigitova E. M.
Relevance of the topic
• high infection rate of the child population;
• increase in the incidence of infectious diseases
mononucleosis and chronic infection;
• lack of specific prevention and specific
etiotropic therapy;
• polymorphism of clinical manifestations;
Plan of the lecture
• Definition of " Infectious
mononucleosis»
• Etiology, epidemiology
• Pathogenesis
• Classification
• Clinical picture
• Differential diagnosis
• Laboratory diagnostics
• Treatment
• Prevention
Infectious mononucleosis in children
Infectious mononucleosis-
this is an acute viral disease (mainly
Epstein-Barr virus), which is
characterized by fever,
oropharyngeal lesions, lymph
nodes, liver, spleen, and peculiar
changes in the blood composition
(lymphomonocytosis, atypical
mononuclears).
https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRPfyhtNjME-_E-
XWQS8ml37tvWvR4o6OSOEueZKrulQnxDxgdxSg&s
Epidemiology
• infectious mononucleosis-anthroponosis;
• the source of infection is a sick person, a virus
carrier;
• the path of transmission is airborne (most often
with saliva - "kissing disease", "disease of
patched children"), with blood transfusions,
during childbirth;
• susceptibility-high;
• seasonality-spring-autumn;
• immunity is strong, but non-sterile;
• possible chronization and reactivation of the
infection.
Patients are contagious
• at the end of the incubation period (2 to 8 weeks);
• in the prodromal period;
• in the period of reconvalescence (from 1 to 18 months).
Infectious mononucleosis is
characterized by:
• Cyclicity with a duration epidemiological waves of
6-7 years.
• Development of the epidemic process mostly due to
erased and asymptomatic forms.
• Preemptive defeat of men's faces gender.
• The highest incidence among children of preschool age,
organized in children's groups.
• It is more common in the form of sporadic more cases
than epidemic outbreaks.
• Mortality is low, descriptions of the cases single
deaths.
• Cause of death-rupture of the liver, spleen, the defeat of
the cardiovascular system and Central nervous system.
• Prenatal protective antibodies saved for 3-6 months.
Etiology
•Epstein-Barr virus :
•contains DNA
•the diameter of 120-150 nm
Сontains antigens:
• capsid (VCA),
•nuclear(EBNA),
•early (EA)
• membrane (MA).
https://сдатьанализ74.рф/upload/iblock/7ef/Virus-epshteyn-barr-2.jpg
Pathogenesis
•replication of EB virus in the nasopharyngeal epithelium and
nasopharyngeal lymphatic formations;
• hematogenous and lymphogenous dissemination of the virus;
• infection of B-lymphocytes, activation of T-suppressors that
suppress proliferation of B-lymphocytes;
• young T-suppressor cells have the appearance of atypical
mononuclear cells;
•activation of the lymphatic system is manifested by an increase in
lymph nodes, tonsils, and other lymphoid formations of the spleen,
liver, pharynx.
Атипичные
мононуклеары
https://meduniver.com/Medical/gematologia/Img/mazok_krovi_pri_infekcionnom_mononukleo
ze.jpg
CLASSIFICATION of INFECTIOUS MONONUCLEOSIS
(N. I. Nisevich, 1990)
By type:
• typical;
• atypical (asymptomatic, erased, visceral).
According to the severity:
• • mild form;
• • medium-heavy form;
• • severe form.
CLASSIFICATION OF INFECTIOUS
MONONUCLEOSIS
Course of infectious mononucleosis
• On duration:Acute (up to 3 months);
• Prolonged (up to 6 months);
• Chronic (more than 6 months);
In character:
• Smooth;
• Wavy;
• Recurrent;
• Complicated;
COMPLICATIONS:
• EARLY COMPLICATIONS (1-3 weeks
of illness):
• ruptured spleen,
• asphyxia, (due to edema
pharyngotonsillitis),
• myocarditis,
• interstitial pneumonia, encephalitis,
• cranial nerve paralysis,
• including bell's paralysis,
• meningoencephalitis,
• polyneuritis,
• Guillain-Barre syndrome;
• LATE COMPLICATIONS (after 3 weeks
of illness):
• hemolytic anemia, thrombocytopenic
purpura,
• aplastic anemia,
• hepatitis,
• malabsorption syndrome, etc., as a
consequence of the autoimmune process.
CLINIC OF INFECTIOUS
MONONUCLEOSIS
INTOXICATION SYNDROME (priority) :
• pallor, lethargy, weakness, headache,
• fever (high, persistent, prolonged):
• - light severity: up to 38.0 ° C, no more than 38.5
° C;
• - average severity: up to 39.0 ° C, no more than
39.5 ° C;
• - severe severity: more than 39.0 ° C;
CLINIC OF INFECTIOUS
MONONUCLEOSIS
Catarrhal respiratory syndrome (primary):
• Nasal congestion;
• Lack of nasal breathing;
• Breathing with an open mouth;
• Catarrh of the nasopharyngeal mucosa: Palatine
arches, tonsils, posterior pharyngeal wall;
• Snoring breath;
• Puffiness of the eyelids, face;
CLINIC OF INFECTIOUS MONONUCLEOSIS
Lymphadenopathy
syndrome-100%
(priority)
• Reaction and enlargement of
lymph nodes:
• Anterior and / or posterior neck
• Submandibular;
• Occipital;
• Parotid
• Axillary;
• Inguinal;
• Intra-abdominal lymph nodes;
• Most often at the gate of the
liver and spleen,
• Hypertrophy of the Palatine and
pharyngeal tonsils
https://encrypted-
tbn0.gstatic.com/images?q=tbn:ANd9GcQZGIVFFrDpFHFdk23xldyEx2wbPC
CC_7zziEimWefyfKWYgm7x&s
ENLARGEMENT OF CERVICALAND
SUBMANDIBULAR LYMPH NODES IN
INFECTIOUS MONONUCLEOSIS
http://womanclub.site/wp-
content/uploads/2019/08/dce64d2c5a7c6abc4e1a34fe487e7e00.png
CLINIC OF INFECTIOUS
MONONUCLEOSIS
THE SYNDROME OF ANGINA:
• Very often (up to 85% of cases) in children, various
overlays appear on the Palatine and nasopharyngeal
tonsils in the form of Islands and stripes; they completely
cover the Palatine tonsils.
• Overlays of a whitish-yellowish or dirty-gray color,
loose, bumpy, rough, easily removed, the tonsillar tissue
after removing the plaque usually does not bleed.
• Overlays are sometimes partially fibrinous, dense, not
completely rubbed between slides.
• Possible and follicular angina, and very rarely-necrotic.
• Overlays on the tonsils may appear in the first days of the
disease, sometimes after 3-4 days.
ANGINA IN INFECTIOUS MONONUCLEOSIS
http://diagnoster.ru/wp-content/uploads/2013/02/Infektsionnyiy-mononukleoz-gorlo.jpg
https://s.zakon.kz/Cache/041269/041269868.JPG
CLINIC OF INFECTIOUS
MONONUCLEOSIS
HEPATOLIENAL SYNDROME (in 97-98% of
cases):
• The liver begins to grow from the first
days of illness, and its size reaches a
maximum of 4-10 days from the
beginning of the disease. The edge of
the liver becomes dense, sharp, and
slightly painful on palpation.
Sometimes there is a slight jaundice of
the skin and sclera.
• All patients who came under
observation in the first 3 days from the
onset of the disease, it is possible to
palpate the enlarged spleen. The
maximum increase in the spleen is
observed on day 4-10.
http://simptomed.ru/upload/content/infe
kcionniy-mononukleoz-u-detey.jpg
Liver cell cytolysis syndrome and disorders of liver pigment
(bilirubin) metabolism
• Increasing alanine aminotransferase, aspartate
aminotransferase.
• Disorder of pigment metabolism of the liver manifested by
jaundice and increased bilirubin
CLINIC OF INFECTIOUS
MONONUCLEOSIS
Rash syndrome:
• The rash is spotty-papular, less often
hemorrhagic with localization on the face, trunk,
limbs, more often proximal parts, bright,
abundant, sometimes draining.
• Possible skin itching, swelling of the face.
• Appears on 5-10 days of illness.
Rash with mononucleosis
https://encrypted-
tbn0.gstatic.com/images?q=tbn:ANd9GcSRgeVihnhQkHh4lofoIGGlhMbWaHiKaPbpSzOGZ88OPScIg
H7a&s
Differential diagnosis
• Adenovirus infection:fever, polyadenopatiya,
enlargement of the spleen and liver, pharyngitis,
tonsillitis.
• Measles: fever, polyadenopatiya, puffy face, rash.
• Cmvi (mononucleosis-like form): Fever,
polyadenopathy, hepatolienal syndrome, increased
activity of liver enzymes, adenoiditis, tonsillitis.
• HIV (mononucleosis-like syndrome): Fever,
polyadenopathy, rash, hepatolienal syndrome.
• Acute tonsillitis: tonsillitis, lymphadenitis.
Laboratory research
• CBC: leukopenia / moderate leukocytosis (12-25x109/l);
lymphomonocytosis up to 70-80%; neutropenia; increase in
ESR up to 20-30 mm / h; atypical mononuclears (absence or
increase from 10 to 50%).
• Serological (ELISA with determination of the avidity index):
determination of the avidity index) detection of specific
antibodies IgM VCA to EBV and IgG VCA, IgG EA, IgG-
EBNA to EBV with determination of the avidity index index
Additional laboratory tests:
• Molecular genetic method (PCR): detection of Epstein-Barr
virus DNA in the blood.
• Biochemical blood analysis (for hepatomegaly and jaundice):
determination of the concentration of bilirubin and ALAT in the
blood: moderate hyperfermentemia, hyperbilirubinemia.
• Bacteriological examination of mucus from the tonsils and
the back wall of the pharynx for aerobic and optionally
anaerobic microorganisms: to identify the bacterial etiology of
acute tonsillitis.
TREATMENT TACTICS AT THE
HOSPITAL LEVEL:
Non-drug treatment :
• Mode: bed rest (during the fever period) semi-flat; patient
hygiene: hygienic care of the mucous membranes of the mouth,
nose toilet.
• Diet: table №13, №5 (with liver damage) fractional warm
drink, dairy plant diet;
Principles of therapy at the hospital level
• for the relief of hyperthermic syndrome over 38.5 o C,
paracetamol is prescribed 10-15 mg / kg at intervals of at
least 4 hours, no more than three days through the mouth
or per rectum or ibuprofen at a dose of 5-10 mg/kg no
more than 3 times a day through the mouth;
• infusion therapy is indicated for patients with severe
disease (infusion volume from 30 to 50 ml/kg of body
weight per day) with the inclusion of solutions: 5% or
10% dextrose (10-15 ml / kg), 0.9% sodium chloride (10-
15 ml/kg);
• hormone therapy is used for complications such as
encephalitis and thrombocytopenic purpura;
• for convulsions-diazepam 0.5% solution (0.2-0.5 mg/kg) in /
m; or in / in; or rectally;
• antibacterial therapy for purulent tonsillitis of
staphylococcal or streptococcal etiology (Staphylococcus
aureus, Streptococcus pyogenes) - cefuroxime 50-100 mg/kg
per day in / m 2-3 times a day for 5-7 days or Ceftriaxone 50-80
mg/kg per day in / m 1-2 times a day for 5-7 days. NB
NB!
In infectious mononucleosis, the following antibiotics are
contraindicated: ampicillin-due to the frequent appearance of a
rash and the development of a drug disease; chloramphenicol, as
well as sulfonamides – due to the oppression of hematopoiesis.
• Further management: discharge of patients with
infectious mononucleosis from the hospital is carried out
after the disappearance of clinical symptoms, but earlier
than 7 days from the moment of the disease;
• dispensary observation by a child infectious disease
doctor/GP for 1 year;
• doctor's examination once a quarter to determine the
severity of lymphadenopathy, hepatosplenomegaly, the
presence of atypical mononuclears in the blood and the
concentration of Alat and ASAT.
• compliance with diet №5 (if hepatitis is detected) for 6
months after infectious mononucleosis;
• medical withdrawal from physical education for 3
months;
• recommendations for the patient-limit insolation for 1
year;
• reconvalescents who have undergone viral-bacterial
pneumonia-medical examination within 1 year (with control
clinical and laboratory examinations in 3 (mild form), 6
(moderate form) and 12 months (severe form) after the disease;
convalescents who have suffered damage to the nervous system
(meningitis, encephalitis, meningoencephalitis) – at least 2
years, with control clinical laboratory examinations 1 time in 3
months during the first year, then 1 time in 6 months. in
subsequent years.
Prevention
• specific prevention measures have not been developed
(there is no vaccine) ;
• General prevention measures are similar to those for SARS;
• compliance with personal hygiene rules;
• non-specific prevention-increasing the overall and
immunological resistance of the body.
Sources
• Clinical Protocol of diagnosis and treatment
"Infectious mononucleosis in children", 2017
(Efendiev I. M. with co-authors)
• V. F. Uchaykin, N. I. Nisevich, O. V. Shamsheva.
Infectious diseases in children; textbook-Moscow:
GEOTAR-Media, 2010. – 688 p.: Il.
Thank you for
your attention!!!

More Related Content

Similar to mononucleosis lecture mbbs medicine.ppt.

Similar to mononucleosis lecture mbbs medicine.ppt. (20)

Imn csbrp
Imn csbrpImn csbrp
Imn csbrp
 
Non resolving pneumonia
Non resolving pneumoniaNon resolving pneumonia
Non resolving pneumonia
 
Case study on spleenomegaly with portal hypertension
Case study on spleenomegaly with portal hypertensionCase study on spleenomegaly with portal hypertension
Case study on spleenomegaly with portal hypertension
 
Acute bacterial meningitis
Acute bacterial meningitisAcute bacterial meningitis
Acute bacterial meningitis
 
The Spleen : Trauma & Portal Hypertension
The Spleen : Trauma & Portal HypertensionThe Spleen : Trauma & Portal Hypertension
The Spleen : Trauma & Portal Hypertension
 
Meningitis
MeningitisMeningitis
Meningitis
 
Meningitis.pptx
Meningitis.pptxMeningitis.pptx
Meningitis.pptx
 
Meningitis
MeningitisMeningitis
Meningitis
 
Meningitis
MeningitisMeningitis
Meningitis
 
GR 11 NEPHROTIC AND NEPHRITIC SYNDROME.pptx
GR 11 NEPHROTIC AND NEPHRITIC SYNDROME.pptxGR 11 NEPHROTIC AND NEPHRITIC SYNDROME.pptx
GR 11 NEPHROTIC AND NEPHRITIC SYNDROME.pptx
 
Necrotizing enterocolitis
Necrotizing enterocolitisNecrotizing enterocolitis
Necrotizing enterocolitis
 
Neonatal sepsis by Dr vijitha
Neonatal sepsis by Dr vijitha Neonatal sepsis by Dr vijitha
Neonatal sepsis by Dr vijitha
 
Typhoid fever (Enteric fever)
Typhoid fever (Enteric fever)Typhoid fever (Enteric fever)
Typhoid fever (Enteric fever)
 
Mumps
MumpsMumps
Mumps
 
Pyrexia of unkown origin by Dr mohammed Hussien
Pyrexia of unkown origin by Dr mohammed HussienPyrexia of unkown origin by Dr mohammed Hussien
Pyrexia of unkown origin by Dr mohammed Hussien
 
16. enterobacteriaceae
16. enterobacteriaceae16. enterobacteriaceae
16. enterobacteriaceae
 
IMN.pptx
IMN.pptxIMN.pptx
IMN.pptx
 
Liver abscess
Liver abscessLiver abscess
Liver abscess
 
Pyrexia of unknown origin
Pyrexia of unknown originPyrexia of unknown origin
Pyrexia of unknown origin
 
Typhoid fever overview
Typhoid fever overview Typhoid fever overview
Typhoid fever overview
 

Recently uploaded

Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45
Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45
Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45MysoreMuleSoftMeetup
 
factors influencing drug absorption-final-2.pptx
factors influencing drug absorption-final-2.pptxfactors influencing drug absorption-final-2.pptx
factors influencing drug absorption-final-2.pptxSanjay Shekar
 
Neurulation and the formation of the neural tube
Neurulation and the formation of the neural tubeNeurulation and the formation of the neural tube
Neurulation and the formation of the neural tubeSaadHumayun7
 
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdfDanh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdfQucHHunhnh
 
Matatag-Curriculum and the 21st Century Skills Presentation.pptx
Matatag-Curriculum and the 21st Century Skills Presentation.pptxMatatag-Curriculum and the 21st Century Skills Presentation.pptx
Matatag-Curriculum and the 21st Century Skills Presentation.pptxJenilouCasareno
 
Application of Matrices in real life. Presentation on application of matrices
Application of Matrices in real life. Presentation on application of matricesApplication of Matrices in real life. Presentation on application of matrices
Application of Matrices in real life. Presentation on application of matricesRased Khan
 
....................Muslim-Law notes.pdf
....................Muslim-Law notes.pdf....................Muslim-Law notes.pdf
....................Muslim-Law notes.pdfVikramadityaRaj
 
Behavioral-sciences-dr-mowadat rana (1).pdf
Behavioral-sciences-dr-mowadat rana (1).pdfBehavioral-sciences-dr-mowadat rana (1).pdf
Behavioral-sciences-dr-mowadat rana (1).pdfaedhbteg
 
Removal Strategy _ FEFO _ Working with Perishable Products in Odoo 17
Removal Strategy _ FEFO _ Working with Perishable Products in Odoo 17Removal Strategy _ FEFO _ Working with Perishable Products in Odoo 17
Removal Strategy _ FEFO _ Working with Perishable Products in Odoo 17Celine George
 
Basic Civil Engg Notes_Chapter-6_Environment Pollution & Engineering
Basic Civil Engg Notes_Chapter-6_Environment Pollution & EngineeringBasic Civil Engg Notes_Chapter-6_Environment Pollution & Engineering
Basic Civil Engg Notes_Chapter-6_Environment Pollution & EngineeringDenish Jangid
 
philosophy and it's principles based on the life
philosophy and it's principles based on the lifephilosophy and it's principles based on the life
philosophy and it's principles based on the lifeNitinDeodare
 
Post Exam Fun(da) Intra UEM General Quiz 2024 - Prelims q&a.pdf
Post Exam Fun(da) Intra UEM General Quiz 2024 - Prelims q&a.pdfPost Exam Fun(da) Intra UEM General Quiz 2024 - Prelims q&a.pdf
Post Exam Fun(da) Intra UEM General Quiz 2024 - Prelims q&a.pdfPragya - UEM Kolkata Quiz Club
 
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...Sayali Powar
 
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General Quiz
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General QuizPragya Champions Chalice 2024 Prelims & Finals Q/A set, General Quiz
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General QuizPragya - UEM Kolkata Quiz Club
 
slides CapTechTalks Webinar May 2024 Alexander Perry.pptx
slides CapTechTalks Webinar May 2024 Alexander Perry.pptxslides CapTechTalks Webinar May 2024 Alexander Perry.pptx
slides CapTechTalks Webinar May 2024 Alexander Perry.pptxCapitolTechU
 
size separation d pharm 1st year pharmaceutics
size separation d pharm 1st year pharmaceuticssize separation d pharm 1st year pharmaceutics
size separation d pharm 1st year pharmaceuticspragatimahajan3
 
[GDSC YCCE] Build with AI Online Presentation
[GDSC YCCE] Build with AI Online Presentation[GDSC YCCE] Build with AI Online Presentation
[GDSC YCCE] Build with AI Online PresentationGDSCYCCE
 
Open Educational Resources Primer PowerPoint
Open Educational Resources Primer PowerPointOpen Educational Resources Primer PowerPoint
Open Educational Resources Primer PowerPointELaRue0
 

Recently uploaded (20)

Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45
Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45
Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45
 
factors influencing drug absorption-final-2.pptx
factors influencing drug absorption-final-2.pptxfactors influencing drug absorption-final-2.pptx
factors influencing drug absorption-final-2.pptx
 
Neurulation and the formation of the neural tube
Neurulation and the formation of the neural tubeNeurulation and the formation of the neural tube
Neurulation and the formation of the neural tube
 
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdfDanh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
 
Matatag-Curriculum and the 21st Century Skills Presentation.pptx
Matatag-Curriculum and the 21st Century Skills Presentation.pptxMatatag-Curriculum and the 21st Century Skills Presentation.pptx
Matatag-Curriculum and the 21st Century Skills Presentation.pptx
 
Application of Matrices in real life. Presentation on application of matrices
Application of Matrices in real life. Presentation on application of matricesApplication of Matrices in real life. Presentation on application of matrices
Application of Matrices in real life. Presentation on application of matrices
 
....................Muslim-Law notes.pdf
....................Muslim-Law notes.pdf....................Muslim-Law notes.pdf
....................Muslim-Law notes.pdf
 
Behavioral-sciences-dr-mowadat rana (1).pdf
Behavioral-sciences-dr-mowadat rana (1).pdfBehavioral-sciences-dr-mowadat rana (1).pdf
Behavioral-sciences-dr-mowadat rana (1).pdf
 
Post Exam Fun(da) Intra UEM General Quiz - Finals.pdf
Post Exam Fun(da) Intra UEM General Quiz - Finals.pdfPost Exam Fun(da) Intra UEM General Quiz - Finals.pdf
Post Exam Fun(da) Intra UEM General Quiz - Finals.pdf
 
Removal Strategy _ FEFO _ Working with Perishable Products in Odoo 17
Removal Strategy _ FEFO _ Working with Perishable Products in Odoo 17Removal Strategy _ FEFO _ Working with Perishable Products in Odoo 17
Removal Strategy _ FEFO _ Working with Perishable Products in Odoo 17
 
Basic Civil Engg Notes_Chapter-6_Environment Pollution & Engineering
Basic Civil Engg Notes_Chapter-6_Environment Pollution & EngineeringBasic Civil Engg Notes_Chapter-6_Environment Pollution & Engineering
Basic Civil Engg Notes_Chapter-6_Environment Pollution & Engineering
 
philosophy and it's principles based on the life
philosophy and it's principles based on the lifephilosophy and it's principles based on the life
philosophy and it's principles based on the life
 
Post Exam Fun(da) Intra UEM General Quiz 2024 - Prelims q&a.pdf
Post Exam Fun(da) Intra UEM General Quiz 2024 - Prelims q&a.pdfPost Exam Fun(da) Intra UEM General Quiz 2024 - Prelims q&a.pdf
Post Exam Fun(da) Intra UEM General Quiz 2024 - Prelims q&a.pdf
 
“O BEIJO” EM ARTE .
“O BEIJO” EM ARTE                       .“O BEIJO” EM ARTE                       .
“O BEIJO” EM ARTE .
 
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
UNIT – IV_PCI Complaints: Complaints and evaluation of complaints, Handling o...
 
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General Quiz
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General QuizPragya Champions Chalice 2024 Prelims & Finals Q/A set, General Quiz
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General Quiz
 
slides CapTechTalks Webinar May 2024 Alexander Perry.pptx
slides CapTechTalks Webinar May 2024 Alexander Perry.pptxslides CapTechTalks Webinar May 2024 Alexander Perry.pptx
slides CapTechTalks Webinar May 2024 Alexander Perry.pptx
 
size separation d pharm 1st year pharmaceutics
size separation d pharm 1st year pharmaceuticssize separation d pharm 1st year pharmaceutics
size separation d pharm 1st year pharmaceutics
 
[GDSC YCCE] Build with AI Online Presentation
[GDSC YCCE] Build with AI Online Presentation[GDSC YCCE] Build with AI Online Presentation
[GDSC YCCE] Build with AI Online Presentation
 
Open Educational Resources Primer PowerPoint
Open Educational Resources Primer PowerPointOpen Educational Resources Primer PowerPoint
Open Educational Resources Primer PowerPoint
 

mononucleosis lecture mbbs medicine.ppt.

  • 1. DEPARTMENT of CHILDREN's infectious diseases Discipline: Children's infectious diseases Topic of the lecture: Infectious mononucleosis in children 4 course, level of development: DT, P Lecturer: assistant Erzhigitova E. M.
  • 2. Relevance of the topic • high infection rate of the child population; • increase in the incidence of infectious diseases mononucleosis and chronic infection; • lack of specific prevention and specific etiotropic therapy; • polymorphism of clinical manifestations;
  • 3. Plan of the lecture • Definition of " Infectious mononucleosis» • Etiology, epidemiology • Pathogenesis • Classification • Clinical picture • Differential diagnosis • Laboratory diagnostics • Treatment • Prevention
  • 4. Infectious mononucleosis in children Infectious mononucleosis- this is an acute viral disease (mainly Epstein-Barr virus), which is characterized by fever, oropharyngeal lesions, lymph nodes, liver, spleen, and peculiar changes in the blood composition (lymphomonocytosis, atypical mononuclears). https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRPfyhtNjME-_E- XWQS8ml37tvWvR4o6OSOEueZKrulQnxDxgdxSg&s
  • 5. Epidemiology • infectious mononucleosis-anthroponosis; • the source of infection is a sick person, a virus carrier; • the path of transmission is airborne (most often with saliva - "kissing disease", "disease of patched children"), with blood transfusions, during childbirth; • susceptibility-high; • seasonality-spring-autumn; • immunity is strong, but non-sterile; • possible chronization and reactivation of the infection.
  • 6. Patients are contagious • at the end of the incubation period (2 to 8 weeks); • in the prodromal period; • in the period of reconvalescence (from 1 to 18 months).
  • 7. Infectious mononucleosis is characterized by: • Cyclicity with a duration epidemiological waves of 6-7 years. • Development of the epidemic process mostly due to erased and asymptomatic forms. • Preemptive defeat of men's faces gender. • The highest incidence among children of preschool age, organized in children's groups. • It is more common in the form of sporadic more cases than epidemic outbreaks. • Mortality is low, descriptions of the cases single deaths. • Cause of death-rupture of the liver, spleen, the defeat of the cardiovascular system and Central nervous system. • Prenatal protective antibodies saved for 3-6 months.
  • 8. Etiology •Epstein-Barr virus : •contains DNA •the diameter of 120-150 nm Сontains antigens: • capsid (VCA), •nuclear(EBNA), •early (EA) • membrane (MA). https://сдатьанализ74.рф/upload/iblock/7ef/Virus-epshteyn-barr-2.jpg
  • 9. Pathogenesis •replication of EB virus in the nasopharyngeal epithelium and nasopharyngeal lymphatic formations; • hematogenous and lymphogenous dissemination of the virus; • infection of B-lymphocytes, activation of T-suppressors that suppress proliferation of B-lymphocytes; • young T-suppressor cells have the appearance of atypical mononuclear cells; •activation of the lymphatic system is manifested by an increase in lymph nodes, tonsils, and other lymphoid formations of the spleen, liver, pharynx. Атипичные мононуклеары https://meduniver.com/Medical/gematologia/Img/mazok_krovi_pri_infekcionnom_mononukleo ze.jpg
  • 10. CLASSIFICATION of INFECTIOUS MONONUCLEOSIS (N. I. Nisevich, 1990) By type: • typical; • atypical (asymptomatic, erased, visceral). According to the severity: • • mild form; • • medium-heavy form; • • severe form.
  • 11. CLASSIFICATION OF INFECTIOUS MONONUCLEOSIS Course of infectious mononucleosis • On duration:Acute (up to 3 months); • Prolonged (up to 6 months); • Chronic (more than 6 months); In character: • Smooth; • Wavy; • Recurrent; • Complicated;
  • 12. COMPLICATIONS: • EARLY COMPLICATIONS (1-3 weeks of illness): • ruptured spleen, • asphyxia, (due to edema pharyngotonsillitis), • myocarditis, • interstitial pneumonia, encephalitis, • cranial nerve paralysis, • including bell's paralysis, • meningoencephalitis, • polyneuritis, • Guillain-Barre syndrome; • LATE COMPLICATIONS (after 3 weeks of illness): • hemolytic anemia, thrombocytopenic purpura, • aplastic anemia, • hepatitis, • malabsorption syndrome, etc., as a consequence of the autoimmune process.
  • 13. CLINIC OF INFECTIOUS MONONUCLEOSIS INTOXICATION SYNDROME (priority) : • pallor, lethargy, weakness, headache, • fever (high, persistent, prolonged): • - light severity: up to 38.0 ° C, no more than 38.5 ° C; • - average severity: up to 39.0 ° C, no more than 39.5 ° C; • - severe severity: more than 39.0 ° C;
  • 14. CLINIC OF INFECTIOUS MONONUCLEOSIS Catarrhal respiratory syndrome (primary): • Nasal congestion; • Lack of nasal breathing; • Breathing with an open mouth; • Catarrh of the nasopharyngeal mucosa: Palatine arches, tonsils, posterior pharyngeal wall; • Snoring breath; • Puffiness of the eyelids, face;
  • 15. CLINIC OF INFECTIOUS MONONUCLEOSIS Lymphadenopathy syndrome-100% (priority) • Reaction and enlargement of lymph nodes: • Anterior and / or posterior neck • Submandibular; • Occipital; • Parotid • Axillary; • Inguinal; • Intra-abdominal lymph nodes; • Most often at the gate of the liver and spleen, • Hypertrophy of the Palatine and pharyngeal tonsils https://encrypted- tbn0.gstatic.com/images?q=tbn:ANd9GcQZGIVFFrDpFHFdk23xldyEx2wbPC CC_7zziEimWefyfKWYgm7x&s
  • 16. ENLARGEMENT OF CERVICALAND SUBMANDIBULAR LYMPH NODES IN INFECTIOUS MONONUCLEOSIS http://womanclub.site/wp- content/uploads/2019/08/dce64d2c5a7c6abc4e1a34fe487e7e00.png
  • 17. CLINIC OF INFECTIOUS MONONUCLEOSIS THE SYNDROME OF ANGINA: • Very often (up to 85% of cases) in children, various overlays appear on the Palatine and nasopharyngeal tonsils in the form of Islands and stripes; they completely cover the Palatine tonsils. • Overlays of a whitish-yellowish or dirty-gray color, loose, bumpy, rough, easily removed, the tonsillar tissue after removing the plaque usually does not bleed. • Overlays are sometimes partially fibrinous, dense, not completely rubbed between slides. • Possible and follicular angina, and very rarely-necrotic. • Overlays on the tonsils may appear in the first days of the disease, sometimes after 3-4 days.
  • 18. ANGINA IN INFECTIOUS MONONUCLEOSIS http://diagnoster.ru/wp-content/uploads/2013/02/Infektsionnyiy-mononukleoz-gorlo.jpg https://s.zakon.kz/Cache/041269/041269868.JPG
  • 19. CLINIC OF INFECTIOUS MONONUCLEOSIS HEPATOLIENAL SYNDROME (in 97-98% of cases): • The liver begins to grow from the first days of illness, and its size reaches a maximum of 4-10 days from the beginning of the disease. The edge of the liver becomes dense, sharp, and slightly painful on palpation. Sometimes there is a slight jaundice of the skin and sclera. • All patients who came under observation in the first 3 days from the onset of the disease, it is possible to palpate the enlarged spleen. The maximum increase in the spleen is observed on day 4-10. http://simptomed.ru/upload/content/infe kcionniy-mononukleoz-u-detey.jpg
  • 20. Liver cell cytolysis syndrome and disorders of liver pigment (bilirubin) metabolism • Increasing alanine aminotransferase, aspartate aminotransferase. • Disorder of pigment metabolism of the liver manifested by jaundice and increased bilirubin
  • 21. CLINIC OF INFECTIOUS MONONUCLEOSIS Rash syndrome: • The rash is spotty-papular, less often hemorrhagic with localization on the face, trunk, limbs, more often proximal parts, bright, abundant, sometimes draining. • Possible skin itching, swelling of the face. • Appears on 5-10 days of illness.
  • 23. Differential diagnosis • Adenovirus infection:fever, polyadenopatiya, enlargement of the spleen and liver, pharyngitis, tonsillitis. • Measles: fever, polyadenopatiya, puffy face, rash. • Cmvi (mononucleosis-like form): Fever, polyadenopathy, hepatolienal syndrome, increased activity of liver enzymes, adenoiditis, tonsillitis. • HIV (mononucleosis-like syndrome): Fever, polyadenopathy, rash, hepatolienal syndrome. • Acute tonsillitis: tonsillitis, lymphadenitis.
  • 24. Laboratory research • CBC: leukopenia / moderate leukocytosis (12-25x109/l); lymphomonocytosis up to 70-80%; neutropenia; increase in ESR up to 20-30 mm / h; atypical mononuclears (absence or increase from 10 to 50%). • Serological (ELISA with determination of the avidity index): determination of the avidity index) detection of specific antibodies IgM VCA to EBV and IgG VCA, IgG EA, IgG- EBNA to EBV with determination of the avidity index index
  • 25. Additional laboratory tests: • Molecular genetic method (PCR): detection of Epstein-Barr virus DNA in the blood. • Biochemical blood analysis (for hepatomegaly and jaundice): determination of the concentration of bilirubin and ALAT in the blood: moderate hyperfermentemia, hyperbilirubinemia. • Bacteriological examination of mucus from the tonsils and the back wall of the pharynx for aerobic and optionally anaerobic microorganisms: to identify the bacterial etiology of acute tonsillitis.
  • 26. TREATMENT TACTICS AT THE HOSPITAL LEVEL: Non-drug treatment : • Mode: bed rest (during the fever period) semi-flat; patient hygiene: hygienic care of the mucous membranes of the mouth, nose toilet. • Diet: table №13, №5 (with liver damage) fractional warm drink, dairy plant diet;
  • 27. Principles of therapy at the hospital level • for the relief of hyperthermic syndrome over 38.5 o C, paracetamol is prescribed 10-15 mg / kg at intervals of at least 4 hours, no more than three days through the mouth or per rectum or ibuprofen at a dose of 5-10 mg/kg no more than 3 times a day through the mouth; • infusion therapy is indicated for patients with severe disease (infusion volume from 30 to 50 ml/kg of body weight per day) with the inclusion of solutions: 5% or 10% dextrose (10-15 ml / kg), 0.9% sodium chloride (10- 15 ml/kg);
  • 28. • hormone therapy is used for complications such as encephalitis and thrombocytopenic purpura; • for convulsions-diazepam 0.5% solution (0.2-0.5 mg/kg) in / m; or in / in; or rectally; • antibacterial therapy for purulent tonsillitis of staphylococcal or streptococcal etiology (Staphylococcus aureus, Streptococcus pyogenes) - cefuroxime 50-100 mg/kg per day in / m 2-3 times a day for 5-7 days or Ceftriaxone 50-80 mg/kg per day in / m 1-2 times a day for 5-7 days. NB
  • 29. NB! In infectious mononucleosis, the following antibiotics are contraindicated: ampicillin-due to the frequent appearance of a rash and the development of a drug disease; chloramphenicol, as well as sulfonamides – due to the oppression of hematopoiesis.
  • 30. • Further management: discharge of patients with infectious mononucleosis from the hospital is carried out after the disappearance of clinical symptoms, but earlier than 7 days from the moment of the disease; • dispensary observation by a child infectious disease doctor/GP for 1 year; • doctor's examination once a quarter to determine the severity of lymphadenopathy, hepatosplenomegaly, the presence of atypical mononuclears in the blood and the concentration of Alat and ASAT. • compliance with diet №5 (if hepatitis is detected) for 6 months after infectious mononucleosis; • medical withdrawal from physical education for 3 months; • recommendations for the patient-limit insolation for 1 year;
  • 31. • reconvalescents who have undergone viral-bacterial pneumonia-medical examination within 1 year (with control clinical and laboratory examinations in 3 (mild form), 6 (moderate form) and 12 months (severe form) after the disease; convalescents who have suffered damage to the nervous system (meningitis, encephalitis, meningoencephalitis) – at least 2 years, with control clinical laboratory examinations 1 time in 3 months during the first year, then 1 time in 6 months. in subsequent years.
  • 32. Prevention • specific prevention measures have not been developed (there is no vaccine) ; • General prevention measures are similar to those for SARS; • compliance with personal hygiene rules; • non-specific prevention-increasing the overall and immunological resistance of the body.
  • 33. Sources • Clinical Protocol of diagnosis and treatment "Infectious mononucleosis in children", 2017 (Efendiev I. M. with co-authors) • V. F. Uchaykin, N. I. Nisevich, O. V. Shamsheva. Infectious diseases in children; textbook-Moscow: GEOTAR-Media, 2010. – 688 p.: Il.
  • 34. Thank you for your attention!!!